V D A I S C A h Fu INT Aci pleo cata pat *C Au 4.0 Vo l. 9(2), p p . 7 DOI: 10.5897/ A Artic le Numb e S SN 1996-0808 Co p yri g ht © 20 Autho r (s ) re ta i n http://www.a c ull Length β-Lact choice Acinetobac critically ill seven path due to the emergence Acinetobac modified K according Acinetobac of A. johns baumanni a isolates of ampicillin-s of A. lwoffii johnsonii a A. baumann sulbactam. Acinetobac having sulb sulbactam, species. Key words: TRODUCTION netobacter is omorphic, no alase-positive thogen. This Corresponding a uthor(s) agree 0International L 8-82, 14 Janua AJMR2014.6840 r: 99518C8501 8 015 n the c o p yri gh c ademic j o urn Research tam - β e thera Farhan R Micro cter, an imp patients wh ogens that d organism’s of multidru cter spp. we Kirby Bauer to CLSI 201 cter johnsoni sonii and all and A. johns A. baumann sulbactam. F i were susce nd no isolat nii, one isola Cefoperazo cter. Ninety bactam were though not Acinetobacte N a Gram nega on-fermenting e and oxid genus consis author. E-mail: that this articl License a ry, 2015 0 23 ht o f this a rtic l e a ls.o r g / AJMR h Paper β-lactam apy for Rasheed*, R obiology Depa Rece portant noso hich results disturb the h capability to ug resistant ere evaluate disc diffusio 12 guideline ii and 6 were l 6 isolates sonii, and no ni, one isola Forty one (41 eptible to pip e of A. lwoff ate of A. joh one-sulbacta one percen more effect an antimicr er, β-lactam – ative cocco-b , non-fastidio dase-negative sts of 35 spe dr.farhanrashe e remain perm e mase i r multi Raja Kamr artment, Com eived 19 April, 20 ocomial path into high m health care o acquire di and pan-dr ed against f on method u es. Out of 1 e Acinetobac of A. lwoffii o isolate of A ate of A. joh 1) isolates of peracillin-su fii were susc nsonii, and n am was the t isolates w tive as comp robial, but do – β-lactamase bacillus, aerob ous, non-mot e opportunis ecies (Turton eed@gmail.co manently open Africa inhibit drug r an Afzal an mbined Military 014; Accepted 22 hogen, is c morbidity and delivery sys iverse resist rug resistant five β-lactam using Muelle 00 isolates, cter lwoffii. E i were multi A. lwoffii wer hnsonii and f A. bauman lbactam. Eig ceptible to pi no isolate of most effec were resistan pared to othe oes possess e inhibitor com bic, ile, stic et al., 2 respo et al. immu m. access under an Journa tor com resista nd Muham y Hospital, La 2 December, 201 capable of c d mortality w stem. The sit tance mecha t strains. A m – β-lactam er-Hinton ag 85 were A ighty four is drug resista re susceptib no isolate o nni, one isola ght isolates o iperacillin-ta f A. lwoffii we ctive combi nt to pipera ers. This wor s antibacteri mbinations, ce 2005). Out o onsible for ab , 2008). Acin unocompromi the terms of t al of Micro mbinat ant Aci mmad Jan L ahore, Pakista 14 causing infe worldwide. It tuation has anisms. This total of 100 mase inhibit gar. Zone si Acinetobacter olates of A. ant. One iso ble to co-amo of A. lwoffii ate of A. john of A. bauma azobactam. F ere suscepti nation agai acillin-tazoba rk also supp ial activity a efoperazone- of these, Ac bout 80% of c netobacter ha sed individua the Creative C obiology R tions a netoba Leghari an. ectious outb t is rated am become com s has resulte 0 clinical is tor combina zes were in r baumannii baumannii, 8 olate from ea oxiclav. Twe were susce nsonii and n anni, one iso Forty eight is ble to cefop nst 49% iso actam. Com port the postu against Acine -sulbactam. cinetobacter clinical condit as a high inci als, particular Commons Attri Research as the acter breaks in mong top mplicated ed in the olates of ations by terpreted i, 9 were 8 isolates ach of A. enty eight eptible to no isolate late of A. solates of perazone- olates of binations ulate that etobacter baumannii i tions (Sebeny dence among rly those who bution License s y g o e